To mechanistically understand the relevance of the downstream transcriptional targets we identified in ccRCC, the next step will be to define PBRM1 binding across the genome and determine cooperating transcription factors. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.